drug

LY3867070

1 story · latest Nov 6, 2026

Follow LY3867070. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Eli Lilly

Timeline

Lilly posts galunisertib PFS results in prostate cancer; registers new bimagrumab HFpEF trial

Nov 6Weekly roundup, 7 itemsbimagrumab Eli LillyUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.